9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 105 filers reported holding 9 METERS BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,000 | -16.7% | 114,899 | -0.0% | 0.00% | – |
| Q2 2022 | $30,000 | +76.5% | 114,914 | +301.3% | 0.00% | – |
| Q1 2022 | $17,000 | -85.3% | 28,633 | -75.7% | 0.00% | – |
| Q4 2021 | $116,000 | +41.5% | 118,066 | +87.1% | 0.00% | – |
| Q3 2021 | $82,000 | +28.1% | 63,097 | +8.2% | 0.00% | – |
| Q2 2021 | $64,000 | +52.4% | 58,300 | +64.1% | 0.00% | – |
| Q1 2021 | $42,000 | -34.4% | 35,520 | -52.7% | 0.00% | – |
| Q4 2020 | $64,000 | +6300.0% | 75,077 | +6172.1% | 0.00% | – |
| Q3 2020 | $1,000 | – | 1,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,250,000 | $1,948,000 | 0.42% |
| ODonnell Financial Services, LLC | 854,375 | $512,000 | 0.23% |
| Orbimed Advisors | 10,275,887 | $6,158,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 419,858 | $252,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $8,990,000 | 0.02% |
| Prentice Wealth Management LLC | 39,525 | $23,000 | 0.01% |
| Ascent Wealth Partners, LLC | 85,224 | $51,000 | 0.01% |
| RWA WEALTH PARTNERS, LLC | 230,888 | $138,000 | 0.01% |
| Sterling Investment Counsel, LLC | 17,533 | $11,000 | 0.01% |
| Valeo Financial Advisors, LLC | 198,148 | $119,000 | 0.01% |